Pfizer's product pipeline is a summary of the investigational
medicines and vaccines that we're currently researching and
testing, but it can mean so much more. Here's what it is and why
you should care.
America's strong intellectual property (IP) system provides
crucial incentives for innovation and helps advance the development of
new medicines. But world leaders are considering a harmful and
unnecessary proposal to weaken IP rights for developers of new
COVID-19 treatments and diagnostics, which could hamper U.S.
innovation, threaten American jobs, and jeopardize our ability to
respond to future pandemics.